CAS 190595 65 4 Ezetimibe Intermediates C31H25F2NO3 cGMP Standard

CAS : 190595-65-4 Ezetimbe Intermediates C31H25F2NO3 cGMP standard

Chemical Name : ( 3R , 4S ) - 4 - [ 4 - ( Benzyloxy ) phenyl ] - 1 - ( 4 - fluorophenyl ) - 3 - [ 3 - ( 4 - fluorophenyl ) - 3 - oxopropyl ] azetidin - 2 - one

CAS No . : 190595-65-4

Molecular Formula : C31H25F2NO3

Molecular Weight : 497.53

Usage : Ezetimibe Intermediates

Description: Ezetimibe is the active pharmaceutical ingredient (API) of branded drug Zetia, or one of the active pharmaceutical ingredients (API) of branded drug Liptruzet (the other API is atorvastatin) or Vytorin (the other API is simivastatin). It was innovated by Schering-Plough Pharmaceuticals and co-marketed with Merck/MSD. Ezetimibe is used to reduce the amount of cholesterol and other fatty substances in the blood. It may be used alone or with other statins such as atorvastatin and simivastatin.

( 3R , 4S ) - 4 - [ 4 - ( Benzyloxy ) phenyl ] - 1 - ( 4 - fluorophenyl ) - 3 - [ 3 - ( 4 - fluorophenyl ) - 3 - oxopropyl ] azetidin - 2 - one CAS No . : 190595-65-4 is one of its intermediates. There are several synthesis routes to manufacture this intermediate but some routes are protected by the patents in some countries. We strictly obey the laws and our commercial products are manufactured without infringing such patents. But anyway, the buyers should know the patent status by themselves. We promise to supply the real route of synthesis to the buyers. The buyers should take the risks of patent infringement by themselves.

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.